Yifan Xinfu Pharmaceutical Co Ltd (002019) — Financial Flexibility Index
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥224.86 Million (operating CF CN¥40.18 Million minus capex CN¥184.68 Million) represents 0% of total liabilities (CN¥4.40 Billion). Also explore how fast is Yifan Xinfu Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Yifan Xinfu Pharmaceutical Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Yifan Xinfu Pharmaceutical Co Ltd across 23 annual periods. Check Yifan Xinfu Pharmaceutical Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Yifan Xinfu Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Yifan Xinfu Pharmaceutical Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥1.02 Billion | CN¥458.37 Million | CN¥4.13 Billion | ▼ -25.1% |
| 2024 | 0.33x | CN¥1.27 Billion | CN¥640.73 Million | CN¥3.86 Billion | ▲ +25.1% |
| 2023 | 0.26x | CN¥852.67 Million | CN¥348.58 Million | CN¥3.24 Billion | ▼ -12.0% |
| 2022 | 0.30x | CN¥1.01 Billion | CN¥472.07 Million | CN¥3.40 Billion | ▲ +16.0% |
| 2021 | 0.26x | CN¥872.97 Million | CN¥301.23 Million | CN¥3.39 Billion | ▼ -57.8% |
| 2020 | 0.61x | CN¥1.82 Billion | CN¥1.11 Billion | CN¥2.99 Billion | ▲ +9.8% |
| 2019 | 0.56x | CN¥1.80 Billion | CN¥937.24 Million | CN¥3.24 Billion | ▼ -15.5% |
| 2018 | 0.66x | CN¥1.90 Billion | CN¥1.17 Billion | CN¥2.89 Billion | ▼ -19.3% |
| 2017 | 0.82x | CN¥1.62 Billion | CN¥1.13 Billion | CN¥1.99 Billion | ▲ +119.8% |
| 2016 | 0.37x | CN¥1.14 Billion | CN¥855.85 Million | CN¥3.08 Billion | ▼ -0.2% |
| 2015 | 0.37x | CN¥619.11 Million | CN¥401.96 Million | CN¥1.67 Billion | ▲ +28.2% |
| 2014 | 0.29x | CN¥229.24 Million | CN¥139.74 Million | CN¥791.21 Million | ▼ -22.9% |
| 2013 | 0.38x | CN¥108.27 Million | CN¥34.32 Million | CN¥288.20 Million | ▲ +123.7% |
| 2012 | 0.17x | CN¥97.52 Million | CN¥29.88 Million | CN¥580.73 Million | ▲ +149.4% |
| 2011 | 0.07x | CN¥46.92 Million | CN¥-52.82 Million | CN¥696.73 Million | ▼ -79.7% |
| 2010 | 0.33x | CN¥165.50 Million | CN¥-33.82 Million | CN¥497.79 Million | ▼ -64.0% |
| 2009 | 0.92x | CN¥209.88 Million | CN¥58.61 Million | CN¥227.31 Million | ▲ +28.1% |
| 2008 | 0.72x | CN¥205.76 Million | CN¥83.31 Million | CN¥285.39 Million | ▼ -42.4% |
| 2007 | 1.25x | CN¥420.77 Million | CN¥248.71 Million | CN¥335.87 Million | ▲ +271.9% |
| 2006 | 0.34x | CN¥90.24 Million | CN¥32.62 Million | CN¥267.92 Million | ▼ -20.2% |
| 2005 | 0.42x | CN¥82.76 Million | CN¥24.12 Million | CN¥196.02 Million | ▼ -80.2% |
| 2004 | 2.13x | CN¥103.73 Million | CN¥33.59 Million | CN¥48.72 Million | ▲ +242.5% |
| 2003 | 0.62x | CN¥65.09 Million | CN¥12.65 Million | CN¥104.73 Million | — |